Brandon Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
22
- Investments
-
83
- Portfolio
-
40
- Exits
-
19
Brandon Capital General Information
Company Description
Founded in 2007, Brandon Capital Partners is a venture capital investment firm based in Melbourne, Australia. The firm prefers to invest in companies operating in the pharmaceuticals, biotechnology, healthcare devices and supplies, life sciences, digital health, healthtech, oncology, and manufacturing sectors in Australia and New Zealand.
Business Details
Website
brandoncapital.vcYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- Level 9
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Brandon Capital Investments (83)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AdvanCell | 03-Feb-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Phrenix Therapeutics | 03-Feb-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Catalym | 16-Jul-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Myricx Bio | 08-Jul-2024 | Drug Discovery | Generating Revenue | |||
| Pheon Therapeutics | 21-May-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Q-Sera | 20-Mar-2024 | Medical Supplies | Generating Revenue | |||
| Pheon Therapeutics | 04-Mar-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Pathios Therapeutics | 20-Feb-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Aravax | 23-Jan-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Allay Therapeutics | 21-Dec-2023 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Brandon Capital Exits (19)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Longas | 04-Feb-2025 | Out of Business | |
| OccuRx | 19-Dec-2024 | ||
| Protego Medical | 16-Dec-2021 | ||
| EBR Systems | 01-Oct-2021 | ||
| Helmedix | 01-Jun-2021 | ||
| Cardiora | 02-Apr-2021 | ||
| GI Therapies | 01-Mar-2021 | ||
| Snap Surveillance | 30-Nov-2020 | ||
| Paragen Bio | 01-Jul-2019 | Out of Business | |
| Auspherix | 30-Apr-2019 | Out of Business |
Brandon Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Brandon Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Brandon Capital Co-Investors (89)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Brandon Biocatalyst | 10 |
|
|
||
| Uniseed |
|
|
|||
| Abingworth |
|
|
|||
| Novartis Venture Fund |
|
|
|||
| Stoic Venture Capital |
|
|
Brandon Capital FAQs
-
What is Brandon Capital?
Founded in 2007, Brandon Capital Partners is a venture capital investment firm based in Melbourne, Australia.
-
When was Brandon Capital founded?
Brandon Capital was founded in 2007.
-
Where is Brandon Capital headquartered?
Brandon Capital is headquartered in Melbourne, Australia.
-
What is Brandon Capital's total asset value?
Brandon Capital has around in total assets under management.
-
How many investments has Brandon Capital made?
Brandon Capital has made 83 investments.
-
What has Brandon Capital invested in?
Brandon Capital has made numerous investments in companies like AdvanCell, Phrenix Therapeutics, and Catalym within the Drug Discovery industry.
-
What has Brandon Capital invested in recently?
Brandon Capital's latest investment was on 03-Feb-2025 in AdvanCell, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
